CN103445263A - Zymolytic ovalbumin compound nutritional oral solution - Google Patents
Zymolytic ovalbumin compound nutritional oral solution Download PDFInfo
- Publication number
- CN103445263A CN103445263A CN2013104231161A CN201310423116A CN103445263A CN 103445263 A CN103445263 A CN 103445263A CN 2013104231161 A CN2013104231161 A CN 2013104231161A CN 201310423116 A CN201310423116 A CN 201310423116A CN 103445263 A CN103445263 A CN 103445263A
- Authority
- CN
- China
- Prior art keywords
- human body
- zymolytic
- ovalbumin
- fruit
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 12
- 108010058846 Ovalbumin Proteins 0.000 title claims abstract description 11
- 229940092253 ovalbumin Drugs 0.000 title claims abstract description 10
- 150000001875 compounds Chemical class 0.000 title claims abstract description 8
- 229940100688 oral solution Drugs 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 235000013399 edible fruits Nutrition 0.000 claims description 14
- 235000015468 Lycium chinense Nutrition 0.000 claims description 13
- 244000241872 Lycium chinense Species 0.000 claims description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims description 11
- 230000035764 nutrition Effects 0.000 claims description 10
- 244000241838 Lycium barbarum Species 0.000 claims description 9
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 9
- 238000002386 leaching Methods 0.000 claims description 7
- 238000010009 beating Methods 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000002131 composite material Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 241000607479 Yersinia pestis Species 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- 229920001184 polypeptide Polymers 0.000 abstract description 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 abstract description 2
- 108010000912 Egg Proteins Proteins 0.000 abstract description 2
- 102000002322 Egg Proteins Human genes 0.000 abstract description 2
- 230000004071 biological effect Effects 0.000 abstract description 2
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 235000014103 egg white Nutrition 0.000 abstract description 2
- 210000000969 egg white Anatomy 0.000 abstract description 2
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- 230000005855 radiation Effects 0.000 abstract description 2
- 230000001133 acceleration Effects 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003889 chemical engineering Methods 0.000 abstract 1
- 230000000120 cytopathologic effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- -1 medical treatment Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a zymolytic ovalbumin compound nutritional oral solution. A modern high technology is used for carrying out biochemical enzymolysis on egg white to obtain a micro-molecule polypeptide with very strong biological activity, namely zymolytic ovalbumin. The polypeptide has different functions on a human body due to different composition structures and the functions are concluded into inhibition, activation, repairing and acceleration. The cytopathic effect is inhibited, the immunity of a human body is boosted, the activity of cells is activated, harmful free radicals to the human body are eliminated, diseased cells of the human body are repaired, the metabolism is improved, and the synthesis and the regulation and controlling of proteins, enzymes and ferments of the human body are accelerated. The zymolytic ovalbumin polypeptide is used as a bioactive peptide, has the physiological functions of resisting mutation, preventing radiation, resisting fatigues, protecting the liver, resisting oxidization, reducing blood fat, reducing blood pressure and the like, and also has huge development and application values in the fields of foods, cosmetics, medical treatment, chemical engineering and the like.
Description
[technical field]
This product design health food technology field, specifically a kind of enzymolysis ovalbumin compound nutrition oral administration.
[background technology]
Utilize modern high technology that egg white is carried out to biochemical enzymolysis, obtaining having the very micromolecule polypeptide of strong biological activity is exactly enzyme-hydrolysis albumen.Polypeptide, because the difference that forms structure has different functions to human body, sums up as suppressing, activate, repair and promoting.Suppress cytopathy, strengthen body immunity; The active cell activity, remove harmful free radical; Repair the cell of pathology of human body, improve metabolism; Promote the synthetic and regulation and control of human body protein, enzyme and ferment.The enzyme-hydrolysis albumen polypeptide is as a kind of biologically active peptide; there is anti-sudden change, radiation proof, antifatigue, protection liver, anti-oxidant, reducing blood lipid, the physiological function such as hypotensive, in fields such as food, cosmetics, medical treatment, chemical industry, have huge development and application to be worth.
Matrimony vine (Lycium barbarum L.) is the Solanaceae Lycium, and the fruit of plant has the effect that nourishing liver and kidney benefiting shrewd head etc. strengthens the human body resistance, is the famous and precious traditional Chinese medicine of China.
Chinese wolfberry fruit is nutritious, includes LBP-X (LBP), flavones, betaine (betaine), 18 seed amino acids, multivitamin (carrotene is maximum), calcium, phosphorus, iron, potassium, organic germanium and growth stimulant.Modern pharmacological research proof matrimony vine reduces blood pressure, and reduces the effects such as cholesterol level.Prevent and treat fatty liver, promote liver cell new life's effect; Malignant tumor patient is improved to the effect of immunologic function.Particularly the polysaccharase immunologic function can be equal to anti-AIDS choice drug AZT, causes the very big concern of international medical community.It also has tonifying kidney and benefiting sperm, moistening lung clearing liver, nourishing blood for improving eyesight, supporing yang improving eyesight, control that void is calmed the nerves, reducing blood lipid blood sugar, anti arteriosclerosis, anticancer, strengthen immunity and the anti-ageing function of waiting for a long time, be the good medicine for the treatment of various diseases, " the angle fruit " that the senior nutrition that is again nourishing, body-building, promotes longevity is generally acknowledge in the world anti-ageing, antitumor, prevent and cure diseases.
This research adopts the high-tech zymolysis technique to obtain the enzyme-hydrolysis albumen powder, be modulated into nutritious, as to strengthen immunity of organisms and applicable adult's taste enzymolysis ovalbumin compound nutrient oral liquor after adding fruit of Chinese wolfberry leaching liquor, for a new way has been opened up in the development and utilization of ovalbumin.
[summary of the invention]
The objective of the invention is to adopt enzyme-hydrolysis albumen and fruit of Chinese wolfberry leaching liquor composite, and a kind of nutrition oral administration that strengthens body immunity obtained.
For achieving the above object, design a kind of enzymolysis ovalbumin compound nutrition oral administration, it is characterized in that adopting following raw material composite and obtain, enzyme-hydrolysis albumen is placed in the reaction vessel with heater, injected water, water is 99.5:0.5 with the ratio of the weight of solids, heating, and heating-up temperature is 30-35 ℃, ratio according to 5:100 adds fruit of Chinese wolfberry leaching liquor to be stirred, mixing time is 1.2-2 hour, after naturally cooling, filter and gets final product to obtain finished product.
Described fruit of Chinese wolfberry leaching liquor adopts following method preparation and obtains: choosing is without disease and pest, without going mouldy high-quality fruit of Chinese wolfberry raw material, after cleaning up with mobile clear water, by matrimony vine and water quality, than 1:10, add 90 ℃ of deionized waters, after soaking 30min, making beating rapidly, material after making beating is lixiviate 30min under 90 ℃ of conditions, with 150 order filter-cloth filterings, filter residue is merged to filtrate twice with same method secondary lixiviate simultaneously, be cooled to 60 ℃, through macroreticular resin decolouring 2.5h, be cooled to room temperature, preserve standby.
The present invention compared with the existing technology, can supplement the nutrient of needed by human, suppresses cytopathy, strengthens body immunity; The active cell activity, remove harmful free radical; Repair the cell of pathology of human body, improve metabolism; Promote the synthetic and regulation and control of human body protein, enzyme and ferment; Tonifying kidney and benefiting sperm, moistening lung clearing liver, nourishing blood for improving eyesight, reduce blood pressure, and reduces cholesterol level, prevents that artery sclerosis and Promote immunity function from improving resistance against diseases anti-senility etc.
[specific embodiment]
Below to further description of the present invention
One, raw material is prepared
1, fruit of Chinese wolfberry lixiviate
Select without disease and pest, without going mouldy high-quality fruit of Chinese wolfberry raw material, wash away silt impurity with mobile clear water, by matrimony vine and water quality, than 1:10, add 90 ℃ of deionized waters, after soaking 30min, making beating rapidly, material after making beating is lixiviate 30min under 90 ℃ of conditions, with 150 order filter-cloth filterings, filter residue is merged to filtrate twice with same method secondary lixiviate simultaneously, be cooled to 60 ℃, through macroreticular resin decolouring 2.5h, be cooled to room temperature, preserve standby.
2, above-mentioned wolfberry can adopt following method to detect
1) assay method of LBP-X
Accurately take matrimony vine 80mg, adding 80% ethanol 50ml puts in conical flask, ultrasonic processing 30min, filter, filter residue 80% ethanol washing 3 times, after filter residue put into to former conical flask together with filter paper add water 60ml, ultrasonic processing 30min, filter, in filtrate dislocation 100ml measuring bottle, constant volume in measuring bottle is put in 2-3 transfer of water washing conical flask, gets 2ml and puts in the 25ml colorimetric cylinder as sample solution.Drying under reduced pressure to the aqueous solution (1mg/ml) of the DEXTROSE ANHYDROUS of constant weight of take is contrast solution, and precision measures 0.2,0.4,0.6,0.8,1.0ml puts in the 25ml colorimetric cylinder is contrast solution preparation calibration curve.Add 5% phenol solution 1ml in the 25ml colorimetric cylinder, shake up, add rapidly sulfuric acid 5ml, shake up, place 10min, put in 40 ℃ of water-baths and be incubated 15min, be cooled to room temperature after taking-up, take corresponding reagent as blank.Wavelength place at 490nm measures absorbance.
2) assay method of general flavone
Precision takes matrimony vine 0.2g, put in the 25ml measuring bottle, adding water 5ml dissolves, then add 65% ethanol constant volume, ultrasonic 30min, filter, precision measures in 2ml to 25ml measuring bottle, 30% ethanolic solution (0.2mg/ml) of rutin of take is contrast solution, precision measures 1, 2, 3, 4, 5ml puts in the 25ml measuring bottle and prepares calibration curve, add successively 2ml water in the 25ml of sample solution and contrast solution measuring bottle, 6m130% ethanol, the 1m15% sodium nitrite solution, after standing 6min, add again the 1m110% aluminum nitrate solution, standing 6min again, add the 10ml sodium hydroxide test solution, 30% ethanol constant volume, standing 15min.Take corresponding reagent as blank.Measure its absorbance under the 500nm wavelength.
2, enzyme-hydrolysis albumen
By market purchasing, obtain
Two, composite
Enzyme-hydrolysis albumen is placed in the reaction vessel with heater, injected water, and water is 99.5:0.5 with the ratio of the weight of solids, heating, heating-up temperature is 30-35 ℃, according to the ratio of 5:100, adds fruit of Chinese wolfberry leaching liquor to be stirred, and mixing time is 1.2-2 hour.After naturally cooling, filter and get final product to obtain finished product.
Three, case
One female patient, 75 years old, AD was COPD concurrent infection, III degree malnutrition.Looking into liver function while being admitted to hospital shows: total protein 45g/L, albumin 20g/L, while being admitted to hospital every day only can take food minute quantity gruel, thin rice gruel and vegetable soup.Through the positive anti-infective treatment that waits, give 2/time of enzyme-hydrolysis albumen nutrition oral administrations every day, 3 times/d, after 20d, liver function is shown total protein 61g/L, albumin 31g/L, original edema, pulmonary infection recovery from illness, be discharged from hospitals upon recovery substantially.
Select 40 routine liver cirrhosis patients, the male sex's 20 examples wherein, women's 20 examples; Year mean age (49.2 ± 17.3).All patients all make a definite diagnosis through inspections such as liver function test, B ultrasonic and gastroscopes.40 routine patients are divided into 2 groups at random, every group of 20 examples.One group is taken white enzyme-hydrolysis albumen nutrition oral administration is experimental group, and one group is taken distilled water is control group.Instructions of taking is every day 3 times, each 10mL, and be 24 weeks the course for the treatment of.Inactive diuretics during oral enzyme-hydrolysis albumen nutrition oral administration, do not transfuse blood and quiet human albumin, to eliminate the impact on curative effect.Experimental group produce effects 10 examples, 8 examples that take a turn for the better, invalid 2 examples; Control group is respectively 2,2,16 examples.
Claims (2)
1. an enzymolysis ovalbumin compound nutrition oral administration, it is characterized in that adopting that following raw material is composite obtains: enzyme-hydrolysis albumen is placed in the reaction vessel with heater, injected water, water is 99.5:0.5 with the ratio of the weight of solids, heating, heating-up temperature is 30-40 ℃, according to the ratio of 5:100, adds fruit of Chinese wolfberry leaching liquor to be stirred, and mixing time is 1.2-2 hour.After naturally cooling, filter and get final product to obtain finished product.
2. the fruit of Chinese wolfberry leaching liquor in enzymolysis ovalbumin compound nutrition oral administration as claimed in claim 1, select without disease and pest, without going mouldy high-quality fruit of Chinese wolfberry raw material, after cleaning up with mobile clear water, add 90 ℃ of deionized waters by matrimony vine and water quality than 1:10, after soaking 30min, making beating rapidly, material after making beating is lixiviate 30min under 90 ℃ of conditions, with 150 order filter-cloth filterings, filter residue is merged to filtrate twice with same method secondary lixiviate simultaneously, be cooled to 60 ℃, through macroreticular resin decolouring 2.5h, be cooled to room temperature, preserve standby.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013104231161A CN103445263A (en) | 2013-09-17 | 2013-09-17 | Zymolytic ovalbumin compound nutritional oral solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013104231161A CN103445263A (en) | 2013-09-17 | 2013-09-17 | Zymolytic ovalbumin compound nutritional oral solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103445263A true CN103445263A (en) | 2013-12-18 |
Family
ID=49728440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013104231161A Pending CN103445263A (en) | 2013-09-17 | 2013-09-17 | Zymolytic ovalbumin compound nutritional oral solution |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103445263A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
| CN113230389A (en) * | 2021-04-29 | 2021-08-10 | 意润健康产业（广州）有限公司 | Application of composition comprising enzymolysis ovalbumin micromolecule active short peptide in preparation of medicines and foods for improving hypoalbuminemia |
| US11160299B2 (en) | 2019-07-11 | 2021-11-02 | Clara Foods Co. | Protein compositions and consumable products thereof |
| CN113616771A (en) * | 2020-05-09 | 2021-11-09 | 吉林省拓华生物科技有限公司 | Lyophilized powder of active protein extracted from placenta Cervi, placenta Cervi oral liquid and their preparation methods |
| CN114081110A (en) * | 2021-11-04 | 2022-02-25 | 杭州佰倍优生物科技有限公司 | Albumin enzymolysis beverage |
| US11279748B2 (en) | 2014-11-11 | 2022-03-22 | Clara Foods Co. | Recombinant animal-free food compositions and methods of making them |
| CN115336700A (en) * | 2022-08-22 | 2022-11-15 | 宁夏华宝枸杞产业有限公司 | Decolorized deacidified clear wolfberry juice and preparation method thereof |
| US12096784B2 (en) | 2019-07-11 | 2024-09-24 | Clara Foods Co. | Protein compositions and consumable products thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5344661A (en) * | 1976-09-30 | 1978-04-21 | Kyupi Kk | Method of producing processed egg white liquid |
| CN1175360A (en) * | 1996-09-01 | 1998-03-11 | 魏剑鸣 | Egg albumin zymolysis matter and preparing process thereof |
| CN1047203C (en) * | 1993-10-07 | 1999-12-08 | 上海益人生化技术开发有限公司 | Enzymolytic egg albumen solution as health-care liquid |
| CN1101700C (en) * | 1997-12-05 | 2003-02-19 | 上海众联生化技术开发有限公司 | Polypeptide oral liquor |
| CN101530195A (en) * | 2008-01-28 | 2009-09-16 | 中国食品发酵工业研究院 | Special diet food formula containing short peptides for puerpera |
| CN101884785A (en) * | 2010-05-28 | 2010-11-17 | 蒋金媛 | Enzymolysis ovalbumin compound oral liquid |
-
2013
- 2013-09-17 CN CN2013104231161A patent/CN103445263A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5344661A (en) * | 1976-09-30 | 1978-04-21 | Kyupi Kk | Method of producing processed egg white liquid |
| CN1047203C (en) * | 1993-10-07 | 1999-12-08 | 上海益人生化技术开发有限公司 | Enzymolytic egg albumen solution as health-care liquid |
| CN1175360A (en) * | 1996-09-01 | 1998-03-11 | 魏剑鸣 | Egg albumin zymolysis matter and preparing process thereof |
| CN1101700C (en) * | 1997-12-05 | 2003-02-19 | 上海众联生化技术开发有限公司 | Polypeptide oral liquor |
| CN101530195A (en) * | 2008-01-28 | 2009-09-16 | 中国食品发酵工业研究院 | Special diet food formula containing short peptides for puerpera |
| CN101884785A (en) * | 2010-05-28 | 2010-11-17 | 蒋金媛 | Enzymolysis ovalbumin compound oral liquid |
Non-Patent Citations (2)
| Title |
|---|
| 潘超然: "卵白蛋白提取及其口服液的研制", 《福建农林大学学报（自然科学版）》 * |
| 甘伯中，等: "枸杞汁的澄清与脱色方法研究", 《中国食物与营养》 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11279748B2 (en) | 2014-11-11 | 2022-03-22 | Clara Foods Co. | Recombinant animal-free food compositions and methods of making them |
| US11518797B2 (en) | 2014-11-11 | 2022-12-06 | Clara Foods Co. | Methods and compositions for egg white protein production |
| US11160299B2 (en) | 2019-07-11 | 2021-11-02 | Clara Foods Co. | Protein compositions and consumable products thereof |
| US11800887B2 (en) | 2019-07-11 | 2023-10-31 | Clara Foods Co. | Protein compositions and consumable products thereof |
| US11974592B1 (en) | 2019-07-11 | 2024-05-07 | Clara Foods Co. | Protein compositions and consumable products thereof |
| US12096784B2 (en) | 2019-07-11 | 2024-09-24 | Clara Foods Co. | Protein compositions and consumable products thereof |
| US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
| US11142754B2 (en) | 2019-08-07 | 2021-10-12 | Clara Foods Co. | Compositions comprising digestive enzymes |
| US11649445B2 (en) | 2019-08-07 | 2023-05-16 | Clara Foods Co. | Compositions comprising digestive enzymes |
| CN113616771A (en) * | 2020-05-09 | 2021-11-09 | 吉林省拓华生物科技有限公司 | Lyophilized powder of active protein extracted from placenta Cervi, placenta Cervi oral liquid and their preparation methods |
| CN113230389A (en) * | 2021-04-29 | 2021-08-10 | 意润健康产业（广州）有限公司 | Application of composition comprising enzymolysis ovalbumin micromolecule active short peptide in preparation of medicines and foods for improving hypoalbuminemia |
| CN114081110A (en) * | 2021-11-04 | 2022-02-25 | 杭州佰倍优生物科技有限公司 | Albumin enzymolysis beverage |
| CN115336700A (en) * | 2022-08-22 | 2022-11-15 | 宁夏华宝枸杞产业有限公司 | Decolorized deacidified clear wolfberry juice and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103445263A (en) | Zymolytic ovalbumin compound nutritional oral solution | |
| CN104137975B (en) | A kind of health care mushroom vegetables and fruits ferment and preparation method thereof | |
| CN102379421B (en) | Preparation method of nutrient solution by enzymolysis of cordyceps militaris | |
| CN103653147A (en) | Wheat peptide anti-fatigue health drink and preparation method thereof | |
| CN101283792A (en) | A kind of preparation method of functional Chinese yam enzymatic hydrolyzate | |
| CN105936927A (en) | Walnut oligopeptide, and preparation technology and use thereof | |
| CN103549112B (en) | Preparation method for peach kernel protein powder | |
| CN113632851A (en) | Multifunctional children growth milk powder and preparation method thereof | |
| CN102008076A (en) | Egg albumen nutrition mixture beneficial to adjustment of immune function and preparation method thereof | |
| CN106472918A (en) | A kind of Herba Dendrobii antioxidation beverage | |
| CN109806383A (en) | Application of an eel peptide in the preparation of immune-promoting food, medicine or health care product | |
| CN106721855A (en) | A kind of solid beverage preparation method for safeguarding men's health | |
| CN102296014A (en) | Preparation method for selenium cordyceps wine | |
| CN105613940A (en) | Method for extracting Chinese chestnut peptide | |
| CN103666905A (en) | Astragalus membranaceus health care wine | |
| CN105695202A (en) | Wine and preparation method thereof | |
| CN109315774A (en) | A kind of Lycium barbarum and Astragalus health food and preparation method thereof | |
| CN105029449A (en) | Healthcare food | |
| CN103952259B (en) | A kind of preparation method of red bean red date bee honey health-care wine | |
| CN110551586A (en) | giant salamander protein peptide health wine and brewing method thereof | |
| CN110731503A (en) | Ginseng, fructus Lycii and Cordyceps tablet, and its preparation method | |
| CN110604295A (en) | Composite bone peptide and preparation method thereof | |
| CN109700999B (en) | A soft extract with effect of increasing leukocyte content, and its preparation method | |
| CN106617104A (en) | Heat-clearing and lung-moistening type walnut polypeptide chewable tablet and preparation method thereof | |
| CN106723043A (en) | A kind of food compositions of three high drop |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131218 |